Year |
Citation |
Score |
2018 |
Sampson C, James M, Whynes D, Eleuteri A, Harding S. OP60 Optimising Risk-Based Screening: The Case Of Diabetic Eye Disease International Journal of Technology Assessment in Health Care. 34: 21-21. DOI: 10.1017/S0266462318001046 |
0.534 |
|
2016 |
Whynes D, Duffy SW, Baldwin DR, Devaraj A, Field JK. Abstract 3458: UK lung cancer screening trial (UKLS) cost effectiveness: similarities with the NLST high-risk quintiles Cancer Research. 76: 3458-3458. DOI: 10.1158/1538-7445.Am2016-3458 |
0.432 |
|
2016 |
Whynes D, Sach T. Sex, benevolence and willingness to pay for screening International Journal of Social Economics. 43: 982-997. DOI: 10.1108/Ijse-09-2014-0192 |
0.327 |
|
2015 |
Sharp L, Cotton S, Cruickshank M, Gray N, Smart L, Whynes D, Little J. Impact of post-colposcopy management on women's long-term worries: results from the UK population-based TOMBOLA trial. The Journal of Family Planning and Reproductive Health Care / Faculty of Family Planning & Reproductive Health Care, Royal College of Obstetricians & Gynaecologists. PMID 26376822 DOI: 10.1136/Jfprhc-2015-101170 |
0.338 |
|
2013 |
Duffy SW, Mackay J, Thomas S, Anderson E, Chen TH, Ellis I, Evans G, Fielder H, Fox R, Gui G, Macmillan D, Moss S, Rogers C, Sibbering M, Wallis M, ... ... Whynes D, et al. Evaluation of mammographic surveillance services in women aged 40-49 years with a moderate family history of breast cancer: a single-arm cohort study. Health Technology Assessment (Winchester, England). 17: vii-xiv, 1-95. PMID 23489892 DOI: 10.3310/Hta17110 |
0.308 |
|
2013 |
Field JK, Baldwin D, Devaraj A, Brain K, Eisen T, Holemans J, Ledson M, Screaton N, Rintoul RC, Yadegarfar G, Hands C, McRonald FE, Lifford K, Whynes D, Kerr K, et al. Abstract 3631: United Kingdom lung cancer screening trial (UKLS): First 88897 approaches. Cancer Research. 73: 3631-3631. DOI: 10.1158/1538-7445.Am2013-3631 |
0.381 |
|
2012 |
Sharp L, Cotton S, Thornton A, Gray N, Cruickshank M, Whynes D, Duncan I, Hammond R, Smart L, Little J. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 165: 318-25. PMID 22921577 DOI: 10.1016/J.Ejogrb.2012.08.001 |
0.309 |
|
2011 |
Field JK, Baldwin D, Brain K, Devaraj A, Eisen T, Duffy SW, Hansell DM, Kerr K, Page R, Parmar M, Weller D, Williamson P, Whynes D. CT screening for lung cancer in the UK: position statement by UKLS investigators following the NLST report. Thorax. 66: 736-7. PMID 21724746 DOI: 10.1136/Thoraxjnl-2011-200351 |
0.381 |
|
2011 |
Field JK, Duffy S, Baldwin D, Brain KE, Eisen T, Hands CJD, Kerr KM, Page R, Parmar M, Wald N, Weller D, Whynes D, Williamson P, Hansell D. United Kingom lung cancer screening (UKLS) trial [Conference abstract] Journal of Thoracic Oncology. DOI: 10.1097/01.Jto.0000399290.73317.Eb |
0.329 |
|
2005 |
Frew EJ, Wolstenholme JL, Whynes DK. Eliciting relative preferences for two methods of colorectal cancer screening. European Journal of Cancer Care. 14: 124-31. PMID 15842459 DOI: 10.1111/J.1365-2354.2005.00515.X |
0.347 |
|
2003 |
Whynes DK, Frew EJ, Edwards R, Atkin WS. Costs of flexible sigmoidoscopy screening for colorectal cancer in the United Kingdom. International Journal of Technology Assessment in Health Care. 19: 384-95. PMID 12862195 DOI: 10.1017/S0266462303000345 |
0.301 |
|
2001 |
Philips Z, Whynes D, Parnham S, Slack R, Earwicker S. The role of community pharmacists in prescribing medication for the treatment of head lice. Journal of Public Health Medicine. 23: 114-20. PMID 11450927 DOI: 10.1093/Pubmed/23.2.114 |
0.327 |
|
2001 |
Frew E, Wolstenholme J, Whynes D. Mass population screening for colorectal cancer: factors influencing subjects' choice of screening test. Journal of Health Services Research & Policy. 6: 85-91. PMID 11357249 DOI: 10.1258/1355819011927279 |
0.371 |
|
2000 |
Avery AJ, Rodgers S, Heron T, Crombie R, Whynes D, Pringle M, Baines D, Petchey R. A prescription for improvement? An observational study to identify how general practices vary in their growth in prescribing costs. Bmj. 321: 276-281. PMID 10915132 DOI: 10.1136/Bmj.321.7256.276 |
0.317 |
|
2000 |
Miller P, Whynes D, Reid A. An economic evaluation of occupational health. Occupational Medicine (Oxford, England). 50: 159-63. PMID 10912357 DOI: 10.1093/Occmed/50.3.159 |
0.31 |
|
1998 |
Baines D, Whynes D. The use of the ASTRO-PU and the ASTRO(97)-PU in the setting of prescribing budgets in English general practice. Journal of Clinical Pharmacy and Therapeutics. 23: 229-234. PMID 9831975 DOI: 10.1046/J.1365-2710.1998.00157.X |
0.301 |
|
1997 |
Wolstenholme J, Whynes D. OP32. The cost of cervical cancer: Implications for screening European Journal of Cancer. 33. DOI: 10.1016/S0959-8049(97)85912-6 |
0.382 |
|
1997 |
Wolstenholme J, Whynes D. OP31. The cost of breast cancer: Implications for screening European Journal of Cancer. 33. DOI: 10.1016/S0959-8049(97)85911-4 |
0.349 |
|
1997 |
Whynes D, Walker A, Neilson A. OP30. Cost-effectiveness of faecal occult blood screening for colorectal cancer: results of the Nottingham trial European Journal of Cancer. 33. DOI: 10.1016/S0959-8049(97)85910-2 |
0.381 |
|
1993 |
Whynes D, Walker A, Chamberlain J, Hardcastle J. Screening and the costs of treating colorectal cancer. British Journal of Cancer. 68: 965-968. PMID 8217610 DOI: 10.1038/Bjc.1993.462 |
0.393 |
|
Show low-probability matches. |